Identification, characterization and suppression of side-products formed during the synthesis of high dose 68Ga-DOTA-TATE

Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data

Michael Hofmann, Helmut R. Maëcke, A. Börner et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 541 citations

Medicine, Nuclear Medicine, Radiology +14

Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE

Irene Virgolini, Valentina Ambrosini, Jamshed Bomanji et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 447 citations

Medicine, Nuclear Medicine, Radiology +16

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

Pedro Antunes, Mihaela Ginj, Hanwen Zhang et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 392 citations · Full text

Medicine, Oncology, Radiology +13

Expression of somatostatin receptor types 1–5 in 81 cases of gastrointestinal and pancreatic endocrine tumors

Mauro Papotti, Massimo Bongiovanni, Marco Volante et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2002 · 334 citations

Medicine, Endocrinology, Oncology +11

The Role of ⁶⁸Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on ¹¹¹In-DTPA-Octreotide Scintigraphy

Rajaventhan Srirajaskanthan, Irfan Kayani, Anne Marie Quigley et al. · Journal of Nuclear Medicine · 2010 · 307 citations · Full text

Medicine, Nuclear Medicine, Radiology +16